Indirubin-3'-oxime as an antiviral and immunomodulatory agent in treatment of severe human influenza virus infection

Hong Kong Med J. 2018 Oct;24 Suppl 6(5):45-47.

Authors

M Cw Chan¹, R Wy Chan¹, C Kp Mok^{1

2}, N K Mak³, R Ns Wong³

Affiliations

¹ Centre of Influenza Research, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong.
² The HKU-Pasteur Research Pole, School of Public Health, LKS Faculty of Medicine, The University of Hong Kong.
³ Department of Biology, Faculty of Science, Hong Kong Baptist University.

PMID: 30229739

No abstract available

MeSH terms

Animals
Antiviral Agents / pharmacology*
Cells, Cultured
Cytokines / antagonists & inhibitors
Epithelial Cells / drug effects*
Epithelial Cells / virology
Humans
Indoles / pharmacology*
Influenza A Virus, H5N1 Subtype / drug effects*
Macrophages / drug effects*
Macrophages / virology
Mice
Oximes / pharmacology*
Virus Replication / drug effects

Substances

Antiviral Agents
Cytokines
Indoles
Oximes
indirubin-3'-monoxime